Standard

Многоуровневая магнитная стимуляция в терапии нейрогенных расстройств функций тазовых органов у пациентов с позвоночно-спинномозговой травмой. / Лобзин, Владимир Юрьевич; Соловьёв, Д.А.; Лупанов, И.А.; Фрунза, Д.Н.; Родионов, А.С.; Яцкевич, Д.Э.; Дынин, Павел Сергеевич; Литвиненко, Игорь Вячеславович.

In: МЕДИЦИНСКИЙ АЛФАВИТ, No. 21, 23.10.2025, p. 21-26.

Research output: Contribution to journalArticlepeer-review

Harvard

Лобзин, ВЮ, Соловьёв, ДА, Лупанов, ИА, Фрунза, ДН, Родионов, АС, Яцкевич, ДЭ, Дынин, ПС & Литвиненко, ИВ 2025, 'Многоуровневая магнитная стимуляция в терапии нейрогенных расстройств функций тазовых органов у пациентов с позвоночно-спинномозговой травмой', МЕДИЦИНСКИЙ АЛФАВИТ, no. 21, pp. 21-26. https://doi.org/10.33667/2078-5631-2025-21-21-26

APA

Лобзин, В. Ю., Соловьёв, Д. А., Лупанов, И. А., Фрунза, Д. Н., Родионов, А. С., Яцкевич, Д. Э., Дынин, П. С., & Литвиненко, И. В. (2025). Многоуровневая магнитная стимуляция в терапии нейрогенных расстройств функций тазовых органов у пациентов с позвоночно-спинномозговой травмой. МЕДИЦИНСКИЙ АЛФАВИТ, (21), 21-26. https://doi.org/10.33667/2078-5631-2025-21-21-26

Vancouver

Author

Лобзин, Владимир Юрьевич ; Соловьёв, Д.А. ; Лупанов, И.А. ; Фрунза, Д.Н. ; Родионов, А.С. ; Яцкевич, Д.Э. ; Дынин, Павел Сергеевич ; Литвиненко, Игорь Вячеславович. / Многоуровневая магнитная стимуляция в терапии нейрогенных расстройств функций тазовых органов у пациентов с позвоночно-спинномозговой травмой. In: МЕДИЦИНСКИЙ АЛФАВИТ. 2025 ; No. 21. pp. 21-26.

BibTeX

@article{bcaf2e206e54452390656aa14e7eae4b,
title = "Многоуровневая магнитная стимуляция в терапии нейрогенных расстройств функций тазовых органов у пациентов с позвоночно-спинномозговой травмой",
abstract = "Each year, 35–40 million cases of spinal cord injury (SCI) are registered worldwide. Among these, 80–100% of patients become disabled or die. In 20% of cases, disability results from neurogenic pelvic organ dysfunction (urination and defecation disorders). This study assessed the effectiveness of multilevel magnetic stimulation (MMS), which combines peripheral, spinal, and transcranial rhythmic magnetic stimulation techniques, in patients with SCI and neurogenic pelvic dysfunction. A total of 30 patients with traumatic SCI were examined. The control group (n=15) received standard therapy, while the experimental group (n=15) additionally underwent MMS. The results showed that MMS was most effective in patients with thoracic spinal cord injuries, demonstrating significant improvements in urinary outflow (p=0.024), bladder filling function (p=0.020), and compensation of urination according to the O. A. Perlmuter{\textquoteright}s scale (p=0.038). No statistically significant improvement was observed in the control group. These findings suggest that MMS is a promising method for the rehabilitation of neurogenic pelvic dysfunction in patients with SCI.",
author = "Лобзин, {Владимир Юрьевич} and Д.А. Соловьёв and И.А. Лупанов and Д.Н. Фрунза and А.С. Родионов and Д.Э. Яцкевич and Дынин, {Павел Сергеевич} and Литвиненко, {Игорь Вячеславович}",
year = "2025",
month = oct,
day = "23",
doi = "10.33667/2078-5631-2025-21-21-26",
language = "русский",
pages = "21--26",
journal = "МЕДИЦИНСКИЙ АЛФАВИТ",
issn = "2078-5631",
publisher = "Альфамед",
number = "21",

}

RIS

TY - JOUR

T1 - Многоуровневая магнитная стимуляция в терапии нейрогенных расстройств функций тазовых органов у пациентов с позвоночно-спинномозговой травмой

AU - Лобзин, Владимир Юрьевич

AU - Соловьёв, Д.А.

AU - Лупанов, И.А.

AU - Фрунза, Д.Н.

AU - Родионов, А.С.

AU - Яцкевич, Д.Э.

AU - Дынин, Павел Сергеевич

AU - Литвиненко, Игорь Вячеславович

PY - 2025/10/23

Y1 - 2025/10/23

N2 - Each year, 35–40 million cases of spinal cord injury (SCI) are registered worldwide. Among these, 80–100% of patients become disabled or die. In 20% of cases, disability results from neurogenic pelvic organ dysfunction (urination and defecation disorders). This study assessed the effectiveness of multilevel magnetic stimulation (MMS), which combines peripheral, spinal, and transcranial rhythmic magnetic stimulation techniques, in patients with SCI and neurogenic pelvic dysfunction. A total of 30 patients with traumatic SCI were examined. The control group (n=15) received standard therapy, while the experimental group (n=15) additionally underwent MMS. The results showed that MMS was most effective in patients with thoracic spinal cord injuries, demonstrating significant improvements in urinary outflow (p=0.024), bladder filling function (p=0.020), and compensation of urination according to the O. A. Perlmuter’s scale (p=0.038). No statistically significant improvement was observed in the control group. These findings suggest that MMS is a promising method for the rehabilitation of neurogenic pelvic dysfunction in patients with SCI.

AB - Each year, 35–40 million cases of spinal cord injury (SCI) are registered worldwide. Among these, 80–100% of patients become disabled or die. In 20% of cases, disability results from neurogenic pelvic organ dysfunction (urination and defecation disorders). This study assessed the effectiveness of multilevel magnetic stimulation (MMS), which combines peripheral, spinal, and transcranial rhythmic magnetic stimulation techniques, in patients with SCI and neurogenic pelvic dysfunction. A total of 30 patients with traumatic SCI were examined. The control group (n=15) received standard therapy, while the experimental group (n=15) additionally underwent MMS. The results showed that MMS was most effective in patients with thoracic spinal cord injuries, demonstrating significant improvements in urinary outflow (p=0.024), bladder filling function (p=0.020), and compensation of urination according to the O. A. Perlmuter’s scale (p=0.038). No statistically significant improvement was observed in the control group. These findings suggest that MMS is a promising method for the rehabilitation of neurogenic pelvic dysfunction in patients with SCI.

UR - https://www.mendeley.com/catalogue/a68bb518-cf69-303b-ac96-72a97aba943a/

U2 - 10.33667/2078-5631-2025-21-21-26

DO - 10.33667/2078-5631-2025-21-21-26

M3 - статья

SP - 21

EP - 26

JO - МЕДИЦИНСКИЙ АЛФАВИТ

JF - МЕДИЦИНСКИЙ АЛФАВИТ

SN - 2078-5631

IS - 21

ER -

ID: 142828199